RESEARCH PEPTIDE SUPPLY

Research peptides supplied with clarity and confidence.

Discover a curated peptide catalog with clear specifications, competitive options, and the information needed to choose with confidence.

Browse Peptides

Clear Specifications

Secure Checkout

Responsive Support

QUALITY & DOCUMENTATION

Available Documentation, Clearly Presented

Review available supplier documentation, independently commissioned reports, and group testing associated with selected products and samples in the Arche Research catalog.

Quality Standards

THE ARCHE STANDARD

Research Materials You Can
Order With Confidence

A carefully selected catalog, straightforward product details, accessible testing documentation, and responsive support—built for researchers who expect consistency from product selection through final delivery.

Purposefully Selected

A focused range of frequently requested research compounds, useful strengths, and formulation options—without an overloaded catalog of unnecessary listings.

Documentation That Matters

Product specifications and available third-party testing are presented clearly so you can evaluate each listing before placing an order.

Simple, Reliable Fulfillment

Clear payment instructions, tracked shipping, discreet packaging, volume options, and local fulfillment where available.

Support Beyond Checkout

Direct assistance is available for product questions, payment confirmation, order status, shipment tracking, and fulfillment concerns.

Ready to Explore the Catalog? Review current availability, strengths, documentation, and volume options.
Shop Research Materials

RESEARCH NOTES

Recent Research & Industry Developments

Selected publications, research summaries, testing information, and developments relevant to the compounds represented in the Arche Research catalog.

  • The “Triple-G” Weight Loss Drug That Could Outperform Ozempic

    Topic: Eli Lilly’s retatrutide Phase 3 success — plans FDA filing for “Triple-G” obesity peptide (July 23, 2026) You’ve heard of Ozempic (semaglutide) and Mounjaro (tirzepatide) — the injectable weight loss drugs that have dominated headlines for the past two years. Eli Lilly just announced results from five Phase 3 clinical trials for a new…

  • FDA Panel Says “Yes” to Peptides You’ve Been Hearing About

    Topic: FDA Committee votes to allow compounding of BPC-157, KPV, TB-500, MOTS-c, Semax & Epitalon (July 23, 2026) If you’ve spent any time in fitness circles, longevity clinics, or even just scrolling wellness social media, you’ve probably heard names like BPC-157 or MOTS-c thrown around. These short protein fragments called peptides have built a massive…

  • A Peptide You Inhale — Could This Change How We Treat Lung Disease?

    Topic: Kither Biotech’s KIT2014 inhaled peptide completes Phase I trial (June 2026) If you or someone you love has COPD, cystic fibrosis, or chronic bronchitis, you know that current treatments are limited. Inhalers help open airways. Steroids reduce inflammation. But there’s no treatment that does both at the same time — and does it well.…